4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099831
Director sold 222,603 shares at an average $46.61 ($10,375,620)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…